PortfoliosLab logoPortfoliosLab logo
EOG vs. UTHR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EOG vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in EOG Resources, Inc. (EOG) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EOG achieves a 32.39% return, which is significantly higher than UTHR's 12.05% return. Over the past 10 years, EOG has underperformed UTHR with an annualized return of 8.50%, while UTHR has yielded a comparatively higher 17.67% annualized return.


EOG

1D
0.09%
1M
1.27%
YTD
32.39%
6M
28.71%
1Y
17.36%
3Y*
10.45%
5Y*
15.40%
10Y*
8.50%

UTHR

1D
0.10%
1M
-5.79%
YTD
12.05%
6M
10.52%
1Y
90.80%
3Y*
33.49%
5Y*
24.97%
10Y*
17.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EOG vs. UTHR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EOG
EOG Resources, Inc.
32.39%-11.37%4.30%-2.03%56.88%88.62%-38.64%-2.82%-18.66%7.47%
UTHR
United Therapeutics Corporation
12.05%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%

Correlation

The correlation between EOG and UTHR is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Jun 17, 1999

0.20

The correlation between EOG and UTHR shifts across timeframes, from -0.01 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

EOG:

$73.11B

UTHR:

$25.77B

EPS

EOG:

$10.16

UTHR:

$27.00

PE Ratio

EOG:

13.45

UTHR:

20.22

PEG Ratio

EOG:

1.71

UTHR:

0.66

PS Ratio

EOG:

3.15

UTHR:

8.21

PB Ratio

EOG:

2.37

UTHR:

4.37

Total Revenue (TTM)

EOG:

$23.48B

UTHR:

$3.17B

Gross Profit (TTM)

EOG:

$11.38B

UTHR:

$2.74B

EBITDA (TTM)

EOG:

$14.73B

UTHR:

$1.75B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EOG vs. UTHR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EOG
EOG Risk / Return Rank: 6161
Overall Rank
EOG Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
EOG Sortino Ratio Rank: 5858
Sortino Ratio Rank
EOG Omega Ratio Rank: 5656
Omega Ratio Rank
EOG Calmar Ratio Rank: 6363
Calmar Ratio Rank
EOG Martin Ratio Rank: 6161
Martin Ratio Rank

UTHR
UTHR Risk / Return Rank: 9494
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EOG vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for EOG Resources, Inc. (EOG) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EOGUTHRDifference
Sharpe ratioReturn per unit of total volatility

-1.26

Sortino ratioReturn per unit of downside risk

-3.16

Omega ratioGain probability vs. loss probability

1.13

1.49

-0.36

Calmar ratioReturn relative to maximum drawdown

0.94

8.58

-7.64

Martin ratioReturn relative to average drawdown

1.82

20.13

-18.31

EOG vs. UTHR - Sharpe Ratio Comparison

The current EOG Sharpe Ratio is 0.67, which is lower than the UTHR Sharpe Ratio of 1.92. The chart below compares the historical Sharpe Ratios of EOG and UTHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EOG vs. UTHR - Drawdown Comparison

The maximum EOG drawdown since its inception was -77.13%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for EOG and UTHR.


Loading charts...

Drawdown Indicators


EOGUTHRDifference

Max Drawdown

Largest peak-to-trough decline

-77.13%

-93.18%

+16.05%

Max Drawdown (1Y)

Largest decline over 1 year

-18.51%

-10.64%

-7.87%

Max Drawdown (3Y)

Largest decline over 3 years

-23.72%

-33.00%

+9.28%

Max Drawdown (5Y)

Largest decline over 5 years

-33.42%

-33.00%

-0.42%

Max Drawdown (10Y)

Largest decline over 10 years

-77.13%

-55.56%

-21.57%

Current Drawdown

Current decline from peak

-8.13%

-8.51%

+0.38%

Average Drawdown

Average peak-to-trough decline

-21.97%

-35.31%

+13.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.55%

4.53%

+5.02%

Volatility

EOG vs. UTHR - Volatility Comparison

EOG Resources, Inc. (EOG) has a higher volatility of 8.72% compared to United Therapeutics Corporation (UTHR) at 5.01%. This indicates that EOG's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EOGUTHRDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.72%

5.01%

+3.71%

Volatility (6M)

Calculated over the trailing 6-month period

21.09%

25.94%

-4.85%

Volatility (1Y)

Calculated over the trailing 1-year period

26.17%

47.55%

-21.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.95%

35.08%

-2.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.13%

35.06%

+4.07%

Dividends

EOG vs. UTHR - Dividend Comparison

EOG's dividend yield for the trailing twelve months is around 2.95%, while UTHR has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
EOG
EOG Resources, Inc.
2.95%3.76%2.97%4.80%6.79%5.19%2.83%1.21%0.87%0.62%0.66%0.95%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

EOG vs. UTHR - Financials Comparison

This section allows you to compare key financial metrics between EOG Resources, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
6.76B
781.50M
(EOG) Total Revenue
(UTHR) Total Revenue
Values in USD except per share items

EOG vs. UTHR - Profitability Comparison

The chart below illustrates the profitability comparison between EOG Resources, Inc. and United Therapeutics Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
82.9%
Portfolio components
EOG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EOG Resources, Inc. reported a gross profit of 0.00 and revenue of 6.76B. Therefore, the gross margin over that period was 0.0%.

UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

EOG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EOG Resources, Inc. reported an operating income of 2.60B and revenue of 6.76B, resulting in an operating margin of 38.4%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

EOG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EOG Resources, Inc. reported a net income of 1.98B and revenue of 6.76B, resulting in a net margin of 29.3%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.


Frequently Asked Questions


EOG and UTHR have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EOG has higher volatility (8.72%) compared to UTHR (5.01%). In terms of maximum drawdown, EOG dropped -77.13% vs UTHR's -93.18%.

UTHR currently has the higher Sharpe Ratio (1.92 vs 0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EOG and UTHR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer